marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Collegium Pharmaceutical Financial Ratios 2011-2024 | COLL
Annual Financial Ratios Collegium Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
32.9 | -120.8 | 8.7 | 31.0 | -29.4 | -13.4 | -9.8 | -4.1 | -8.5 | - | - | - | - |
P/S |
7.0 | 6.7 | 2.3 | 2.7 | 2.3 | 1.9 | 25.8 | 228.3 | - | - | - | - | - |
EPS |
1.0 | -0.2 | 2.0 | 0.8 | -0.7 | -1.2 | -2.5 | -3.9 | -1.5 | -22.7 | -4.1 | - | - |
EV (Enterprise Value) |
1.76 B | 1.68 B | 926 M | 1.11 B | 718 M | 577 M | 646 M | 265 M | 148 M | 15.7 M | -4.1 M | - | - |
EBITDA per Share |
2.02 | 0.43 | 0.55 | 1.66 | -0.247 | 2.74 | -2.47 | -3.85 | -1.97 | - | - | - | - |
EV/EBITDA |
46.3 | 7.8 | -61.7 | 4.3 | -8.2 | -2.6 | -5.3 | - | - | - | - | ||
PEG |
-0.27 | 0.51 | -0.04 | -0.15 | -0.69 | -0.26 | -0.27 | 0.03 | -0.18 | - | - | - | - |
P/B |
5.4 | 4.5 | 3.1 | 4.5 | 7.6 | 5.7 | 7.0 | 2.9 | 2.7 | - | - | - | - |
P/CF |
3.8 | 7.0 | 6.0 | 8.8 | 31.3 | 3.6 | -10.8 | -5.0 | -10.5 | - | - | - | - |
ROE % |
16.34 | -3.69 | 35.24 | 14.38 | -25.99 | -42.72 | -71.93 | -69.81 | -32.04 | - | - | - | - |
ROA % |
2.79 | -0.61 | 10.33 | 4.16 | -7.42 | -13.43 | -55.22 | -58.13 | -27.89 | - | - | - | - |
ROCE % |
31.57 | 6.03 | 8.69 | 30.23 | -22.72 | -20.26 | -72.49 | -68.96 | -30.14 | - | - | - | - |
Current Ratio |
1.2 | 1.2 | 1.4 | 1.4 | 1.3 | 1.3 | 4.2 | 6.2 | 11.5 | - | - | - | - |
DSO |
442.0 | 406.8 | 124.7 | 92.0 | 89.7 | 101.5 | 127.8 | 454.2 | - | - | - | - | - |
DIO |
261.0 | 146.1 | 47.7 | 35.4 | 18.2 | 17.2 | 255.0 | 2255.1 | - | - | - | - | - |
DPO |
40.4 | 17.6 | 20.5 | 22.8 | 11.8 | 26.8 | 799.5 | 15604.2 | - | - | - | - | - |
Operating Cycle |
703.0 | 552.9 | 172.4 | 127.4 | 107.9 | 118.7 | 382.8 | 2709.3 | - | - | - | - | - |
Cash Conversion Cycle |
662.6 | 535.4 | 151.9 | 104.6 | 96.1 | 91.9 | -416.7 | -12894.9 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Collegium Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.29 | 0.6 | - | 0.61 | 0.38 | -0.51 | - | 0.01 | -0.15 | -0.39 | -0.73 | 0.23 | 2.06 | 0.45 | 0.2 | 0.33 | 0.23 | 0.01 | -0.07 | -0.18 | -0.14 | -0.29 | 0.27 | -0.5 | -0.4 | -0.57 | -0.54 | -0.45 | -0.72 | -0.79 | -1.02 | -1.13 | -1.05 | -0.68 | -0.46 | -0.46 | -0.45 | 0.34 | -4.5 | -7.85 | -5.33 | -5.03 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
2.34 | 2.53 | - | 2.41 | 2.11 | 0.74 | - | 1.7 | 1.43 | -0.28 | -0.51 | 0.44 | 0.94 | 0.62 | 0.92 | 0.59 | 0.49 | 0.15 | 0.04 | -0.17 | -0.14 | -0.29 | 0.33 | -0.32 | -0.2 | -0.39 | -0.54 | -0.45 | -0.72 | -0.78 | -1.02 | -1.11 | -1.04 | -0.67 | -0.46 | -0.44 | -0.38 | -3.58 | -3.48 | -6.77 | -4.31 | -4.05 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
36.11 | 38.60 | 8.32 | 8.55 | -2.75 | -11.86 | -9.06 | -21.40 | -18.42 | 12.99 | 28.86 | 44.94 | 47.80 | 23.35 | 14.38 | 8.12 | -4.93 | -14.65 | -25.99 | -13.55 | -24.58 | -33.45 | -42.72 | -69.36 | -64.09 | -70.12 | -71.93 | -75.64 | -82.50 | -80.38 | -69.81 | -60.58 | -51.98 | -39.30 | -32.04 | -16.96 | 1.38 | 11.49 | 20.05 | 16.17 | 8.83 | 4.23 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
5.94 | 6.44 | 1.39 | 1.43 | -0.29 | -2.41 | -2.06 | -5.68 | -3.58 | 6.62 | 10.10 | 14.80 | 15.46 | 6.51 | 4.16 | 2.36 | -1.39 | -4.18 | -7.42 | -3.58 | -7.25 | -10.20 | -13.43 | -29.39 | -33.51 | -44.60 | -55.22 | -59.40 | -65.93 | -65.49 | -58.13 | -50.86 | -44.12 | -33.77 | -27.89 | -86.30 | -205.52 | -281.62 | -352.00 | -283.85 | -155.05 | -74.17 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
87.12 | 89.99 | 56.61 | 66.99 | 52.21 | 40.08 | 10.89 | -5.92 | -10.67 | -9.80 | 7.77 | 32.64 | 37.56 | 39.97 | 30.23 | 19.45 | 1.61 | -13.01 | -27.16 | -12.44 | -17.36 | -19.59 | -22.59 | -51.49 | -52.18 | -64.64 | -72.49 | -76.04 | -82.74 | -80.45 | -69.74 | -60.39 | -51.68 | -38.91 | -31.63 | -16.81 | 1.36 | 11.31 | 19.77 | 16.05 | 8.77 | 4.19 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | - | 1.2 | 1.4 | 1.5 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 4.3 | 4.3 | 4.3 | 4.3 | 6.0 | 6.0 | 6.0 | 6.0 | 7.7 | 7.7 | 7.7 | 7.7 | 0.3 | 0.3 | 0.3 | 0.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
118.1 | 114.1 | - | 116.6 | 116.7 | 114.2 | - | 70.2 | 61.4 | 148.3 | 424.9 | 138.4 | 100.8 | 91.8 | 99.7 | 96.0 | 97.4 | 93.2 | 89.7 | 91.3 | 88.7 | 92.4 | 96.9 | 101.3 | 97.3 | 62.9 | 84.3 | 76.1 | 255.5 | 254.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
48.1 | 50.4 | - | 48.7 | 43.6 | 53.8 | - | 43.3 | 51.4 | 126.2 | 55.3 | 51.5 | 49.0 | 44.2 | 44.5 | 46.0 | 48.0 | 30.7 | 17.9 | 18.8 | 18.1 | 16.2 | 24.0 | 15.5 | 15.2 | 10.2 | 151.2 | 299.2 | 286.7 | 384.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
4.0 | 9.3 | - | 4.9 | 4.0 | 4.4 | - | 5.1 | 2.5 | 10.4 | 18.9 | 21.3 | 22.6 | 26.5 | 28.6 | 29.5 | 30.8 | 19.8 | 11.6 | 12.2 | 11.7 | 17.1 | 37.3 | 24.1 | 23.7 | 18.9 | 474.1 | 937.9 | 898.9 | 1818.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
166.2 | 164.5 | - | 165.2 | 160.2 | 167.9 | - | 113.5 | 112.8 | 274.5 | 480.2 | 189.9 | 149.8 | 136.0 | 144.2 | 142.0 | 145.4 | 123.9 | 107.6 | 110.1 | 106.8 | 108.6 | 120.9 | 116.8 | 112.6 | 73.1 | 235.5 | 375.3 | 542.2 | 638.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
162.1 | 155.2 | - | 160.3 | 156.2 | 163.6 | - | 108.3 | 110.3 | 264.1 | 461.2 | 168.6 | 127.2 | 109.5 | 115.7 | 112.5 | 114.6 | 104.1 | 96.0 | 97.9 | 95.1 | 91.5 | 83.6 | 92.8 | 88.9 | 54.2 | -238.6 | -562.6 | -356.6 | -1179.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency